REIN THERAPEUTICS INC
RNTX·00887A204·US·Common Stock·Healthcare - Biotechnology-13D/G
RNTX (REIN THERAPEUTICS INC) is held by 17 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.3M), GEODE CAPITAL MANAGEMENT, LLC ($448,185), VANGUARD FIDUCIARY TRUST CO ($200,866). Net institutional sentiment: Mixed.
17
Holders
(2 Elite)
$2.4M
Total Value
50% (20)
Consensus
10 buying - 10 selling
13F: Insider & Congress:
Who's Trading
ActivistVOVoss Capital, LP6.6%Jul 14, 2026
ActivistBIBIOS CAPITAL MANAGEMENT, LP10.0%May 8, 2026
ActivistLYLynwood Capital Management Inc.6.1%May 8, 2026
ActivistFUFunicular Funds, LP6.7%May 7, 2026
ActivistLLLYTTON LAURENCE W5.8%May 6, 2026
InsiderWBWINDSOR JAMES BRIANBuy $25KApr 30, 2026
ActivistVVVoss Value Master Fund, LP3.5%Feb 13, 2026
InsiderVLVoss Capital, LPBuy $128KNov 14, 2025
InsiderVLVoss Capital, LPBuy $248KOct 28, 2025
InsiderVLVoss Capital, LPBuy $127KOct 27, 2025
Top Holders
Showing 1-20 of 25
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer